Name: Frank Harvey

Previous title: Managing principle, ATLS Investments

New title: Chief executive officer, Surescripts

Harvey will become the CEO of e-prescription network Surescripts effective June 27, the company said on Monday. He succeeds Tom Skelton, who announced last year that he was retiring after eight years at Virginia-based Surescripts.

Harvey is a pharmacist who's held numerous senior leadership roles in his more than three decades in the health sector. Most recently, the executive led private equity investing in health tech companies for ATLS Investments.

Prior to that, Harvey served as CEO of medication therapy management company Mirixa Corporation and medical equipment supplier Liberty Medical Supply.

Surescripts is still entangled in a federal antitrust lawsuit with the Federal Trade Commission, which sued the company in 2019 over alleged anticompetitive practices. The health IT vendor, which is owned by Express Scripts, CVS Health and two trade groups, also is working to increase its integrations with providers and improve the accuracy of electronic prescriptions.

"I’m honored to join Surescripts at such a critical time, and I look forward to working with the team to realize the enormous potential we have to change healthcare," Harvey said in a statement.